# The Effect of Intermittent Rifampicin on Raltegravir

> **NCT01424826** · PHASE1 · COMPLETED · sponsor: **Helen Reynolds** · enrollment: 18 (actual)

## Conditions studied

- HIV
- Tuberculosis

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Rifampicin
- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT01424826
- **Lead sponsor:** Helen Reynolds
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424826, "The Effect of Intermittent Rifampicin on Raltegravir". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01424826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*